Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 257

1.

Plaques and tangles as well as Lewy-type alpha synucleinopathy are associated with formed visual hallucinations.

Jacobson SA, Morshed T, Dugger BN, Beach TG, Hentz JG, Adler CH, Shill HA, Sabbagh MN, Belden CM, Sue LI, Caviness JN, Hu C; Arizona Parkinson's Disease Consortium.

Parkinsonism Relat Disord. 2014 Sep;20(9):1009-14. doi: 10.1016/j.parkreldis.2014.06.018. Epub 2014 Jun 28.

2.

Neuropathological substrates of psychiatric symptoms in prospectively studied patients with autopsy-confirmed dementia with lewy bodies.

Ballard CG, Jacoby R, Del Ser T, Khan MN, Munoz DG, Holmes C, Nagy Z, Perry EK, Joachim C, Jaros E, O'Brien JT, Perry RH, McKeith IG.

Am J Psychiatry. 2004 May;161(5):843-9.

PMID:
15121649
3.

Limbic neuropathology in idiopathic Parkinson's disease with concomitant dementia.

Bertrand E, Lechowicz W, Szpak GM, Lewandowska E, Dymecki J, Wierzba-Bobrowicz T.

Folia Neuropathol. 2004;42(3):141-50.

PMID:
15535032
4.

Influence of Alzheimer pathology on clinical diagnostic accuracy in dementia with Lewy bodies.

Merdes AR, Hansen LA, Jeste DV, Galasko D, Hofstetter CR, Ho GJ, Thal LJ, Corey-Bloom J.

Neurology. 2003 May 27;60(10):1586-90.

PMID:
12771246
5.

Pathology and temporal onset of visual hallucinations, misperceptions and family misidentification distinguishes dementia with Lewy bodies from Alzheimer's disease.

Ferman TJ, Arvanitakis Z, Fujishiro H, Duara R, Parfitt F, Purdy M, Waters C, Barker W, Graff-Radford NR, Dickson DW.

Parkinsonism Relat Disord. 2013 Feb;19(2):227-31. doi: 10.1016/j.parkreldis.2012.10.013. Epub 2012 Nov 20.

6.

Neuropathological comparisons of amnestic and nonamnestic mild cognitive impairment.

Dugger BN, Davis K, Malek-Ahmadi M, Hentz JG, Sandhu S, Beach TG, Adler CH, Caselli RJ, Johnson TA, Serrano GE, Shill HA, Belden C, Driver-Dunckley E, Caviness JN, Sue LI, Jacobson S, Powell J, Sabbagh MN.

BMC Neurol. 2015 Aug 20;15:146. doi: 10.1186/s12883-015-0403-4.

7.

Clinicopathologic studies in cognitively healthy aging and Alzheimer's disease: relation of histologic markers to dementia severity, age, sex, and apolipoprotein E genotype.

Berg L, McKeel DW Jr, Miller JP, Storandt M, Rubin EH, Morris JC, Baty J, Coats M, Norton J, Goate AM, Price JL, Gearing M, Mirra SS, Saunders AM.

Arch Neurol. 1998 Mar;55(3):326-35.

PMID:
9520006
8.

Olfactory bulb alpha-synucleinopathy has high specificity and sensitivity for Lewy body disorders.

Beach TG, White CL 3rd, Hladik CL, Sabbagh MN, Connor DJ, Shill HA, Sue LI, Sasse J, Bachalakuri J, Henry-Watson J, Akiyama H, Adler CH; Arizona Parkinson's Disease Consortium.

Acta Neuropathol. 2009 Feb;117(2):169-74. doi: 10.1007/s00401-008-0450-7. Epub 2008 Nov 4.

9.

Cortical Lewy bodies and Alzheimer-type changes in patients with Parkinson's disease.

Mattila PM, Röyttä M, Torikka H, Dickson DW, Rinne JO.

Acta Neuropathol. 1998 Jun;95(6):576-82.

PMID:
9650749
10.

Visual hallucinations in Lewy body disease relate to Lewy bodies in the temporal lobe.

Harding AJ, Broe GA, Halliday GM.

Brain. 2002 Feb;125(Pt 2):391-403.

PMID:
11844739
11.

Pedunculopontine cholinergic cell loss in hallucinating Parkinson disease patients but not in dementia with Lewy bodies patients.

Hepp DH, Ruiter AM, Galis Y, Voorn P, Rozemuller AJ, Berendse HW, Foncke EM, van de Berg WD.

J Neuropathol Exp Neurol. 2013 Dec;72(12):1162-70. doi: 10.1097/NEN.0000000000000014.

PMID:
24226265
12.

Lewy body-related alpha-synucleinopathy in the aged human brain.

Jellinger KA.

J Neural Transm (Vienna). 2004 Oct;111(10-11):1219-35. Epub 2004 Apr 2.

PMID:
15480835
13.

Parkinson disease neuropathology: later-developing dementia and loss of the levodopa response.

Apaydin H, Ahlskog JE, Parisi JE, Boeve BF, Dickson DW.

Arch Neurol. 2002 Jan;59(1):102-12.

PMID:
11790237
14.

Neuropathological and genetic correlates of survival and dementia onset in synucleinopathies: a retrospective analysis.

Irwin DJ, Grossman M, Weintraub D, Hurtig HI, Duda JE, Xie SX, Lee EB, Van Deerlin VM, Lopez OL, Kofler JK, Nelson PT, Jicha GA, Woltjer R, Quinn JF, Kaye J, Leverenz JB, Tsuang D, Longfellow K, Yearout D, Kukull W, Keene CD, Montine TJ, Zabetian CP, Trojanowski JQ.

Lancet Neurol. 2017 Jan;16(1):55-65. doi: 10.1016/S1474-4422(16)30291-5.

15.

What are the relations between Lewy body disease and AD?

McKeith IG, Ince P, Jaros EB, Fairbairn A, Ballard C, Grace J, Morris CM, Perry RH.

J Neural Transm Suppl. 1998;54:107-16. Review.

PMID:
9850919
16.

Cognitive status correlates with neuropathologic stage in Parkinson disease.

Braak H, Rüb U, Jansen Steur EN, Del Tredici K, de Vos RA.

Neurology. 2005 Apr 26;64(8):1404-10.

PMID:
15851731
17.

Lewy body cortical involvement may not always predict dementia in Parkinson's disease.

Colosimo C, Hughes AJ, Kilford L, Lees AJ.

J Neurol Neurosurg Psychiatry. 2003 Jul;74(7):852-6.

18.

Pathological α-synuclein distribution in subjects with coincident Alzheimer's and Lewy body pathology.

Toledo JB, Gopal P, Raible K, Irwin DJ, Brettschneider J, Sedor S, Waits K, Boluda S, Grossman M, Van Deerlin VM, Lee EB, Arnold SE, Duda JE, Hurtig H, Lee VM, Adler CH, Beach TG, Trojanowski JQ.

Acta Neuropathol. 2016 Mar;131(3):393-409. doi: 10.1007/s00401-015-1526-9. Epub 2015 Dec 31.

19.

Neocortical lewy body counts correlate with dementia in the Lewy body variant of Alzheimer's disease.

Samuel W, Galasko D, Masliah E, Hansen LA.

J Neuropathol Exp Neurol. 1996 Jan;55(1):44-52.

PMID:
8558171
20.

Apolipoprotein E epsilon4 allele and progression of cortical Lewy body pathology in Parkinson's disease.

Wakabayashi K, Kakita A, Hayashi S, Okuizumi K, Onodera O, Tanaka H, Ishikawa A, Tsuji S, Takahashi H.

Acta Neuropathol. 1998 May;95(5):450-4.

PMID:
9600590

Supplemental Content

Support Center